At the time of writing, Legend Biotech Corp ADR [LEGN] stock is trading at $36.91, down -2.07%. An important factor to consider is whether the stock is rising or falling in short-term value. The LEGN shares have gain 17.44% over the last week, with a monthly amount glided 8.30%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Legend Biotech Corp ADR [NASDAQ: LEGN] stock has seen the most recent analyst activity on October 08, 2024, when Redburn Atlantic initiated its Buy rating and assigned the stock a price target of $86. Previously, Truist started tracking the stock with Buy rating on June 17, 2024, and set its price target to $88. On May 24, 2024, H.C. Wainwright reiterated its Buy rating and revised its price target to $73 on the stock. Deutsche Bank started tracking the stock assigning a Buy rating and suggested a price target of $60 on May 23, 2024. Scotiabank upgraded its rating to a Sector Outperform but $65 remained the price target by the analyst firm on April 17, 2024. Cantor Fitzgerald started tracking with a Overweight rating for this stock on April 03, 2024, and assigned it a price target of $82. In a note dated March 13, 2024, Raymond James initiated an Outperform rating and provided a target price of $86 on this stock.
For the past year, the stock price of Legend Biotech Corp ADR fluctuated between $30.17 and $70.13. Currently, Wall Street analysts expect the stock to reach $89.6 within the next 12 months. Legend Biotech Corp ADR [NASDAQ: LEGN] shares were valued at $36.91 at the most recent close of the market. An investor can expect a potential return of 142.75% based on the average LEGN price forecast.
Analyzing the LEGN fundamentals
According to Legend Biotech Corp ADR [NASDAQ:LEGN], the company’s sales were 520.18M for trailing twelve months, which represents an 66.86% jump. Gross Profit Margin for this corporation currently stands at 0.61% with Operating Profit Margin at -0.54%, Pretax Profit Margin comes in at -0.66%, and Net Profit Margin reading is -0.67%. To continue investigating profitability, this company’s Return on Assets is posted at -0.2, Equity is -0.3 and Total Capital is -0.19. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.31.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 35.83 points at the first support level, and at 34.76 for the second support level. However, for the 1st resistance point, the stock is sitting at 37.94, and for the 2nd resistance point, it is at 38.97.
Ratios To Look Out For
It is important to note that Legend Biotech Corp ADR [NASDAQ:LEGN] has a current ratio of 4.98. On the other hand, the Quick Ratio is 4.90, and the Cash Ratio is 1.7. Considering the valuation of this stock, the price to sales ratio is 13.02, the price to book ratio is 6.07.
Transactions by insiders
Recent insider trading involved Macomber Lori, Former Officer, that happened on Jan 10 ’25 when 2254.0 shares were purchased. Officer, Huang Ying completed a deal on Dec 24 ’24 to buy 63061.0 shares. Meanwhile, Officer Macomber Lori bought 189.0 shares on Dec 24 ’24.
